Development of small macrocyclic kinase inhibitors

Future Med Chem. 2022 Mar;14(6):389-391. doi: 10.4155/fmc-2021-0342. Epub 2022 Jan 14.

Authors

Jin Ma^{1

2

3}, Gonzalo Sanchez-Duffhues¹, Josselin Caradec⁴, Pascal Benderitter⁴, Jan Hoflack⁴, Peter Ten Dijke^{1

2}

Affiliations

¹ Department of Cell & Chemical Biology, Leiden University Medical Center, 2333, ZC Leiden, The Netherlands.
² Oncode Institute, Leiden University Medical Center, 2333, ZC Leiden, The Netherlands.
³ Shenzhen Jingtai Technology Co., Ltd, Floor 3, Sf Industrial Plant, Futian District, Shenzhen, China.
⁴ Oncodesign S.A., Dijon, 21000, France.

PMID: 35029506
DOI: 10.4155/fmc-2021-0342

No abstract available

Keywords: angiogenesis; fibrodysplasia ossificans progressiva; kinase inhibitor; macrocycle; oncology.

Publication types

Editorial
Research Support, Non-U.S. Gov't